Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2024-04-15 00:00:00 ET · period of report 2024-04-11 · accession 0001493152-24-014509 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | 2024-04-11 | IMDX | Arno Andrew | Dir | P - Purchase | $2.95 | +33.9K | 69.1K | +96% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2024-04-11 | P | A | 33,898 | $2.95 | 69,054 | D | — | — | (F1) Reflects shares of the Issuer's common stock, no par value ("Common Stock"), purchased by the Reporting Person from the Issuer in a private offering. |